News Article

Private investment plays a growing role in healthcare and life sciences. How that investment creates value, for patients and staff as well as shareholders, is a question that matters to everyone in the sector.

In November’s HealthcareMarkets, Candesic senior partner Marc Kitten talks about Private Equity in Healthcare and Life Sciences: Strategies, Cases, and Industry Insights, the new book he has co-written with Gilles Chemla of Imperial College London Business School. Drawing on years of advising on healthcare transactions, Marc shares practical lessons for operators and investors, including:

– Why Europe now offers more take-private opportunities than the US
– Where AI is already creating value, from faster drug development to freeing clinicians from admin
– The next wave of opportunity in pharma services outsourcing
– Why retaining clinical talent can make or break a roll-up
– The H.E.A.L. framework, a new way to measure value creation across outcomes, access and sustainability as well as financial returns

It’s a valuable read for anyone investing in, running or advising healthcare businesses, and a taste of what the book offers. You can read the full interview in the LaingBuisson article HERE, or by clicking the link to the right.

If you would like to know more about Marc’s book, CLICK HERE.